NPI: 1245208057 · NORTH MIAMI, FL 33161 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/08/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/08/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,010 | $2.76M |
| 2019 | 30,068 | $4.24M |
| 2020 | 35,341 | $4.88M |
| 2021 | 29,424 | $2.20M |
| 2022 | 18,540 | $1.87M |
| 2023 | 6,055 | $482K |
| 2024 | 923 | $26K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 49,223 | 1,919 | $5.32M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,883 | 2,204 | $4.80M |
| J1270 | Injection, doxercalciferol, 1 mcg | 28,211 | 1,686 | $2.93M |
| A4657 | Syringe, with or without needle, each | 6,973 | 1,918 | $1.16M |
| J1756 | Injection, iron sucrose, 1 mg | 7,768 | 1,389 | $638K |
| 85041 | 2,125 | 1,232 | $249K | |
| 85048 | 2,104 | 1,217 | $248K | |
| 83970 | 1,880 | 1,109 | $245K | |
| 82728 | 1,510 | 981 | $213K | |
| 83540 | 1,453 | 953 | $210K | |
| 85045 | 1,586 | 912 | $189K | |
| 83550 | 1,182 | 773 | $177K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 221 | 120 | $40K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 121 | 71 | $18K |
| 90674 | 23 | 17 | $7K | |
| G0008 | Administration of influenza virus vaccine | 39 | 30 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 59 | 24 | $0.00 |